Share on StockTwits

Select Medical Holdings (NYSE:SEM) Director Thomas Scully sold 9,814 shares of Select Medical Holdings stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $14.07, for a total value of $138,082.98. Following the transaction, the director now directly owns 143,389 shares of the company’s stock, valued at approximately $2,017,483. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Select Medical Holdings (NYSE:SEM) traded down 1.49% on Friday, hitting $13.91. 719,869 shares of the company’s stock traded hands. Select Medical Holdings has a 52-week low of $7.90 and a 52-week high of $16.17. The stock’s 50-day moving average is $15.29 and its 200-day moving average is $13.62. The company has a market cap of $1.809 billion and a P/E ratio of 16.06.

Select Medical Holdings (NYSE:SEM) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.27 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.27. The company had revenue of $772.80 million for the quarter, compared to the consensus estimate of $777.16 million. During the same quarter last year, the company posted $0.27 earnings per share. Select Medical Holdings’s revenue was up 2.1% compared to the same quarter last year. On average, analysts predict that Select Medical Holdings will post $0.94 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, August 29th. Shareholders of record on Wednesday, August 20th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 2.88%. The ex-dividend date is Monday, August 18th.

Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.